May 9 (Reuters) - Strides Shasun Ltd STSA.NS :
* SAYS STRIDES & APOTEX AGREE TO MERGE THEIR AUSTRALIAN BUSINESSES
* SAYS STRIDES TO HAVE CONTROLLING INTEREST IN THE MERGED ENTITY
* SAYS PROPOSED TRANSACTION WILL BE EPS ACCRETIVE FROM YEAR 1 THROUGH MERGER SYNERGIES
* SAYS PROPOSED STRUCTURE WILL BE ARRIVED THROUGH A SHARE SWAP FOR DEAL
* SAYS STRIDES AND APOTEX BUSINESS WILL BE RUN INDEPENDENTLY UNDER THE BRANDS ARROW AND APOTEX
* SAYS HOSPITAL BUSINESS OF APOTEX WILL NOT FORM PART OF THE MERGED ENTITY AND WILL BE RETAINED BY APOTEX
* MERGED BUSINESS TO BE LED BY DENNIS BASTAS, ARROW, AS EXECUTIVE CHAIRMAN, ROGER MILLICHAMP, APOTEX, AS CEO
* SAYS MERGED BUSINESS WILL BE LED BY ANDREW BURGESS, ARROW, AS CFO
* MERGED BUSINESS WILL CONTINUE TO BE SUPPORTED BY STRIDES' AND APOTEX'S MANUFACTURING FACILITIES